11. Breast cancer in young women

International Journal of Clinical Practice

Volumn 56, Issue 3, 2002, Pages 184-187

  Kothari, A S ^a   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HORMONE SENSITIVITY; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; ULTRASOUND;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 0036252477     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Survival patterns among younger women with breast cancer: The effects of age, race, stage, and treatment
2. Breast carcinomas occurring in young women (<35 years) are different
3. Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?
4. The national cancer data base report on breast carcinoma characteristics and outcome in relation to age
5. Prognostic significance of young age in breast cancer
6. Improved survival in young women with breast cancer
7. Pathological prognostic factors in breast cancer. II. Histological type: Relationship with survival in a large study with long-term follow-up
8. Histopathology in relation to age
9. Breast carcinoma in the extremes of age: A comparison of patients younger than 35 years and older than 75 years
10. Intracystic papillary carcinoma of the breast
11. Women 35 years or younger have higher locoregional relapse rates after undergoing breast conservation therapy
12. Early-onset breast cancer: Histopathological and prognostic considerations
13. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinico-pathological correlation
14. Diagnosis of breast cancer in young women
15. Breast cancer in women 35 years old or younger: Clinical and mammographic features
16. Clinical and social problems in young women with breast carcinoma
17. Clinical, radiological and cytological diagnosis of breast cancer in young women
18. Diagnosing breast carcinoma in young women
19. Age as a prognostic factor in premenopausal breast cancer
20. Age as a prognostic factor in premenopausal breast cancer
21. Younger women with breast carcinoma have a poorer prognosis than older women
22. Conservation treatment of early breast cancer: Long term results and complications
23. The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer
24. The effect of young age on tumour recurrence in the treated breast after conservative surgery and radiotherapy
25. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy
26. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of data
27. The influence of young age in early stage breast cancer
28. Is chemotherapy alone adequate for young women with oestrogen-progesterone-positive breast cancer?